This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1980 Mar 29;280(6218):902.

doi: 10.1136/bmj.280.6218.902-a.

Failure of interferon to modify Creutzfeldt-Jakob disease

J Kovanen, M Haltia, K Cantell

PMID: 6155969
PMCID: PMC1601054
DOI: 10.1136/bmj.280.6218.902-a

Case Reports

Failure of interferon to modify Creutzfeldt-Jakob disease

J Kovanen et al. Br Med J. 1980.

. 1980 Mar 29;280(6218):902.

doi: 10.1136/bmj.280.6218.902-a.

Authors

J Kovanen, M Haltia, K Cantell

PMID: 6155969
PMCID: PMC1601054
DOI: 10.1136/bmj.280.6218.902-a

No abstract available

PubMed Disclaimer

Similar articles

Failure to ameliorate Creutzfeldt-Jakob disease with amphotericin B therapy.
Masullo C, Macchi G, Xi YG, Pocchiari M. Masullo C, et al. J Infect Dis. 1992 Apr;165(4):784-5. doi: 10.1093/infdis/165.4.784. J Infect Dis. 1992. PMID: 1552216 No abstract available.
Creutzfeldt-Jakob disease treated with amantadine.
Sanders WL. Sanders WL. J Neurol Neurosurg Psychiatry. 1979 Oct;42(10):960-1. doi: 10.1136/jnnp.42.10.960. J Neurol Neurosurg Psychiatry. 1979. PMID: 390098 Free PMC article.
Unsuccessful treatment of Creutzfeldt-Jakob disease with acyclovir.
David AS, Grant R, Ballantyne JP. David AS, et al. Lancet. 1984 Mar 3;1(8375):512-3. doi: 10.1016/s0140-6736(84)92880-0. Lancet. 1984. PMID: 6142235 No abstract available.
[Creutzfeldt-Jakob disease].
Noguchi-Shinohara M. Noguchi-Shinohara M. Nihon Rinsho. 2007 Mar 28;65 Suppl 3:295-8. Nihon Rinsho. 2007. PMID: 17491402 Review. Japanese. No abstract available.
Emerging pharmacotherapies for Creutzfeldt-Jakob disease.
Korth C, Peters PJ. Korth C, et al. Arch Neurol. 2006 Apr;63(4):497-501. doi: 10.1001/archneur.63.4.497. Arch Neurol. 2006. PMID: 16606761 Review.

See all similar articles

Cited by

Familial Creutzfeldt-Jakob disease in Finland: epidemiological, clinical, pathological and molecular genetic studies.
Haltia M, Kovanen J, Goldfarb LG, Brown P, Gajdusek DC. Haltia M, et al. Eur J Epidemiol. 1991 Sep;7(5):494-500. doi: 10.1007/BF00143128. Eur J Epidemiol. 1991. PMID: 1684756
Insights from Therapeutic Studies for PrP Prion Disease.
Teruya K, Doh-Ura K. Teruya K, et al. Cold Spring Harb Perspect Med. 2017 Mar 1;7(3):a024430. doi: 10.1101/cshperspect.a024430. Cold Spring Harb Perspect Med. 2017. PMID: 27836910 Free PMC article. Review.
Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.
Pollard RB. Pollard RB. Drugs. 1982 Jan-Feb;23(1-2):37-55. doi: 10.2165/00003495-198223010-00002. Drugs. 1982. PMID: 6173188 Review. No abstract available.
Prions: Beyond a Single Protein.
Das AS, Zou WQ. Das AS, et al. Clin Microbiol Rev. 2016 Jul;29(3):633-58. doi: 10.1128/CMR.00046-15. Clin Microbiol Rev. 2016. PMID: 27226089 Free PMC article. Review.
Rapidly progressive dementias and the treatment of human prion diseases.
Appleby BS, Lyketsos CG. Appleby BS, et al. Expert Opin Pharmacother. 2011 Jan;12(1):1-12. doi: 10.1517/14656566.2010.514903. Epub 2010 Nov 23. Expert Opin Pharmacother. 2011. PMID: 21091283 Free PMC article. Review.

References

1. J Gen Virol. 1968 Sep;3(2):295-7 - PubMed
1. Proc Soc Exp Biol Med. 1975 May;149(1):287-9 - PubMed
1. Bull Los Angeles Neurol Soc. 1975 Jan;40(1):18-20 - PubMed
1. Science. 1977 Sep 2;197(4307):943-60 - PubMed
1. J Neurol Sci. 1979 Aug;42(3):381-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information